Johnson & Johnson (JNJ) announced that TREMFYA met the primary and major secondary endpoints demonstrating both improvement in axial symptoms and reduction in inflammation by MRI assessment in the Phase 4 STAR study
Newsquawk Staff ·
Johnson & Johnson (JNJ) announced that TREMFYA met the primary and major secondary endpoints demonstrating both improvement in axial symptoms and reduction in inflammation by MRI assessment in the Phase 4 STAR study.
What it means
Positive readouts from post-marketing studies of this kind tend to matter less for the headline print than for label expansion, guideline positioning, and formulary defence, since the drug is already approved and the question is breadth of use rather than approvability. A Phase 4 win in an axial indication extends the mechanism story into a competitor's core territory, and the established pattern in immunology is that such data shifts share gradually through physician prescribing and payer coverage rather than through an immediate revenue step. The actors to track are the rival incumbents in axial spondyloarthritis and the IL-23 class peers, where differentiation on both symptom and imaging endpoints has historically been the argument used in label and marketing contests. The follow-ons are the full data presentation at a major rheumatology congress, any filing for an expanded indication, and the regulator's posture on the imaging claim. For a large-cap diversified name, single-study readouts of this size have rarely moved the parent equity on their own; the signal accrues to the franchise thesis over quarters. Confidence in the read is moderate given the limited detail in the headline.
Sources
- Johnson & Johnson (JNJ) to acquire Ollin Biosciences and late-stage bispecific antibody with best-in-class potential in ophthalmology; will be USD 2.2bln upfront and USD 1.125bln in milestone payments
- Daily US Conference Calendar - 16-Nov-2026: ORCL, UNH, T, VRTX, MO
- Eli Lilly (LLY) is to buy Calytrix Bio for up to USD 1.5bln in cash
- Johnson & Johnson (JNJ) is eyeing an acquisition of Ollin Biosceinces for up to USD 3.4bn, according to FT
- Merck (MRK) says WELIREG in combination with lenvatinib demonstrated a statistically significant and clinically meaningful improvement in progression-free survival, one of the study's dual primary endpoints, for treatment of ccRCC
Related headlines
- EUROPEAN OPEN: SSNLF to manufacture STM FP chips for SPCX; NOVOB DC updates on CagriSema/Wegovy; AZN LN cuts around 600 US jobs, wins EU myasthenia gravis approval; BARC LN prepares 200 IB job cuts; STLAM IM faces Canada threat over Brampton deal5 hours ago
- Additional European Equity News - 16th November 20265 hours ago
- European Pre-Market Summary - 16th November 2026: European bourses set for a flat open6 hours ago
- Newsquawk Daily European Equity Opening News - 16th November 20266 hours ago
- FDA approves AstraZeneca’s (AZN LN) Imfinzi plus Pfizer (PFE) and Astellas’ (4503 JT) Padcev for muscle-invasive bladder cancer six weeks ahead of schedule2 days ago
- EUROPEAN OPEN: CFR SW H1 op profit up sharply; BC8 GY raises EBT outlook; AMS SW Q3 revenue miss; BOSS GY appoints new CEO; STLAM IM faces potential Canada lawsuit; CARLB DC plans USD 600mln India IPO3 days ago
- Newsquawk Daily European Equity Opening News - 13th November 20263 days ago
- US Market Wrap: Stocks hit on Huang exit and crude jumps on fading US/Iran deal hopes3 days ago
- XPeng (XPEV) expects November deliveries to top 60,000 vehicles, another record after October exceeded 50,000 for the first time; targets Q4 overseas deliveries above 40,000 and FY26 overseas deliveries above 100,0001 hour ago
- JPMorgan (JPM) October master trust net charge-off rate at 1.44% (prev. 1.52% M/M), credit card delinquencies rose to 0.81% (prev. 0.80% M/M)1 hour ago
- Berkshire Hathaway’s (BRK.A/BRK.B) Warren Buffett will convert 6,150 Class A shares into 9.225mln Class B shares and donate Class B shares to four family foundations1 hour ago
- Tyson Foods (TSN) Q4 2026 (USD): EPS 0.61 (exp. 0.65), Revenue 14.6bln (exp. 14.2bln)1 hour ago
- Blackstone (BX) REIT to acquire Amazon (AMZN) data centres in a USD 5bln deal, Bloomberg reports1 hour ago
- Diamondback Energy (FANG) announces Core Midland Basic acquisition with the deal valued at USD 2.15bln1 hour ago
- Capital One (COF) October domestic net charge-offs at 4.02% (prev. 3.86% M/M)2 hours ago